Quaker Chemical (NYSE: KWR) SVP CTO logs RSU vesting, tax withholding and new award

Rhea-AI Filing Summary

Quaker Chemical SVP and CTO Christine Procopio Johnson reported routine equity compensation activity involving restricted stock units (RSUs) and related common shares. On March 15, 2026, 304 RSUs and 2 dividend equivalent rights converted into 306 shares of common stock, reflecting the first installment vesting of a 2025 RSU grant.

To cover withholding taxes on this vesting, 111 shares were surrendered at a price of $118.45 per share, leaving 195 common shares held directly afterward. Johnson also received a new grant of 1,013 time-based RSUs that vest in three annual installments beginning on March 15, 2027, each representing a contingent right to one share of Quaker Chemical common stock with dividend equivalents accruing over time.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Christine Procopio

(Last) (First) (Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN PA 19428-2380

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CTO

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/15/2026		M		304	A	(1)	304	D
Common Stock	03/15/2026		M		2	A	(2)	306	D
Common Stock	03/15/2026		F		111(3)	D	$118.45	195	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/15/2026		M			304	(4)	(4)	Common Stock	304	$0	609	D
Dividend Equivalent Rights	(2)	03/15/2026		M			2	(2)	03/15/2026	Common Stock	2	(2)	0	D
Restricted Stock Units	(5)	03/15/2026		A		1,013		(5)	(5)	Common Stock	1,013	$0	1,013	D

Explanation of Responses:

1. Restricted stock units (RSUs) convert into common stock on a one-for-one basis.

2. Dividend equivalent rights (DERs) accrued on the reporting person's RSUs granted on October 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the first installment of the 2025 RSU grant, which vests on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.

3. Shares surrendered by reporting person to satisfy withholding tax obligation upon partial vesting of RSUs granted on October 15, 2025 under the Company's Long-Term Performance Incentive Plan.

4. On October 15, 2025, the reporting person was granted 913 time-based RSUs, vesting in three annual installments beginning on March 15, 2026.

5. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Christine Procopio Johnson	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did KWR SVP CTO Christine Procopio Johnson report on March 15, 2026?

She reported RSUs and dividend equivalent rights converting into common stock, plus a new RSU grant. 304 RSUs and 2 dividend rights became 306 common shares, and 1,013 new time-based RSUs were awarded under Quaker Chemical’s long-term incentive plan.

How many Quaker Chemical (KWR) shares were used to cover taxes in this Form 4?

A total of 111 KWR common shares were surrendered to satisfy withholding tax obligations. These shares related to the partial vesting of RSUs granted on October 15, 2025, and were applied at a price of $118.45 per share under the company’s long-term incentive plan.

What RSU vesting event did Quaker Chemical (KWR) disclose for Christine Procopio Johnson?

The filing shows 304 RSUs vesting and converting into common stock on March 15, 2026. This represents the first installment of a 913-unit RSU grant awarded on October 15, 2025, which is scheduled to vest in three annual installments starting in 2026.

What new restricted stock units did KWR grant to Christine Procopio Johnson?

She received 1,013 new time-based RSUs that vest in three annual installments beginning March 15, 2027. Each RSU represents a contingent right to one share of Quaker Chemical common stock, and dividend equivalent rights will accrue when dividends are paid on KWR shares.

What are dividend equivalent rights mentioned in the KWR Form 4 filing?

Dividend equivalent rights (DERs) are credits that mirror dividends on underlying RSUs. For Johnson, DERs accrued on RSUs granted October 15, 2025 and were settled in common stock when the first RSU installment vested on March 15, 2026, with each DER equal to one KWR share.

How many Quaker Chemical (KWR) common shares does Christine Procopio Johnson hold after these transactions?

After the reported transactions, she directly holds 195 shares of KWR common stock. This reflects 306 shares received from RSU and dividend right settlement, reduced by 111 shares surrendered to satisfy withholding tax obligations associated with the vesting event.